Penile impotence
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male patients aged between 18 and 75 years old. 2.Clinically diagnosed with erectile dysfunction; 3.Agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Allergic to tadalafil or have contraindications to its use; 2.Have definite contraindications to exercise, such as acute or unstable bone and joint diseases, exercise-induced asthma, or other conditions deemed unsuitable for moderate-intensity exercise by a physician after physical examination. Have severe cardiovascular disease, severe liver or kidney dysfunction, or other serious underlying diseases; 3.Use other medications or therapies for the treatment of erectile dysfunction (ED); 4.Have uncontrolled diabetes or hypertension; 5.Are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Index of Erectile Function (IIEF-5) Score;Sex hormone changes;Changes in erectile hardness and duration of erection;Flow-mediated dilation ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse reactions;Sexual life quality assessment; | — |
Countries
China
Contacts
The First Affiliated Hospital of Kunming Medical University